What Happens in a Baby's Body During NEC
The premature gut is fundamentally different from the mature intestine. Born before 37 weeks — and especially before 32 weeks — the intestinal lining lacks the tight junctions, mucus layer, secretory IgA antibodies, and established microbiome that would normally protect against pathogenic bacterial invasion. When cow's milk-based formula enters this immature gut, it promotes the growth of harmful bacteria — particularly gram-negative rods — while failing to provide the protective proteins and growth factors present in human breast milk. These bacteria adhere to and penetrate the intestinal epithelium, triggering a local and then systemic inflammatory cascade. Cytokines (TNF-alpha, IL-6, IL-8) are released, causing vasospasm and ischemia of the bowel wall. The intestinal tissue, deprived of blood flow, begins to die. Gas-producing bacteria proliferate within the necrotic bowel wall — producing the characteristic X-ray finding of pneumatosis intestinalis. As necrosis progresses, the bowel wall may perforate, spilling intestinal contents into the sterile abdominal cavity and causing peritonitis and septic shock.
The Modified Bell Staging Criteria for NEC
NEC is universally staged using the Modified Bell Staging Criteria, first published in 1978 and refined over subsequent decades. Stage I (Suspected NEC): Systemic signs including temperature instability, apnea, bradycardia, and lethargy; intestinal signs including mild abdominal distension, gastric residuals, and bloody stools. Radiographic findings are normal or mildly abnormal. Management: withhold feeds, monitor closely. Stage IIa (Mildly Ill, Confirmed NEC): Same systemic signs plus absent bowel sounds, definite abdominal tenderness; radiographic pneumatosis intestinalis confirmed. Management: NPO, antibiotics, IV fluids, close monitoring. Stage IIb (Moderately Ill, Confirmed NEC): Metabolic acidosis, thrombocytopenia, mild peritonitis, portal venous gas on X-ray. Management: NPO, antibiotics, consider surgical consultation. Stage IIIa (Severely Ill, Bowel Intact): Severe sepsis, respiratory and metabolic deterioration, marked peritonitis, diffuse abdominal discoloration. Bowel intact on imaging but clinical deterioration prompts surgery. Stage IIIb (Severely Ill, Bowel Perforated): Free intraperitoneal air on X-ray confirming perforation, profound deterioration. Emergency surgery mandatory. Mortality at Stage IIIb exceeds 30% despite aggressive intervention.
Emergency Surgery and What It Means for Your Baby
When NEC progresses to Stage IIb or III, the neonatal surgeon performs emergency laparotomy under general anesthesia. The surgeon removes the necrotic portions of the bowel — called resection. The healthy ends of the bowel are then brought through the abdominal wall as a stoma (ostomy), allowing the bowel to heal over weeks to months before a second surgery reconnects the intestine (re-anastomosis). Some surgeons prefer primary peritoneal drainage as an initial temporizing procedure, particularly for the most critically ill infants, followed by definitive laparotomy when the infant is more stable. The amount of bowel removed determines the long-term prognosis. Infants who retain adequate intestinal length recover intestinal function. Those who lose more than 75% of their small intestine develop Short Bowel Syndrome, facing a lifetime of nutritional management.
Why NEC Cases Qualify as Product Liability Claims
The legal theory in NEC formula cases is that Abbott and Mead Johnson manufactured and sold a defective product — cow's milk-based premature infant formula — without adequate warnings of the NEC risk, despite possessing or having access to decades of peer-reviewed research documenting that risk. The failure-to-warn theory holds that even if the product itself was not inherently defective, the manufacturers were required to warn neonatologists, hospitals, and parents of the known NEC risk so that informed decisions could be made about formula versus human breast milk or pasteurized donor breast milk. Having read the NICU records and established which formula your baby received, an attorney can assess whether the warning deficiency, combined with your baby's NEC diagnosis, supports a viable product liability claim.
Frequently Asked Questions
Related Pages
NEC Evidence and Records: What to Gather and Why It Matters
Building a successful NEC formula case requires three categories of records: (1) NICU feeding logs documenting formula product and volume; (2) diagnostic records confirming the NEC diagnosis; and (3) long-term medical records documenting the lasting harm. You do not need these records before contacting an attorney — your attorney can obtain them for you — but understanding what is needed helps families gather and preserve evidence.
NEC Statute of Limitations: State-by-State Deadlines and Minor Tolling Rules
The statute of limitations for NEC formula cases is among the most nuanced in all of mass tort law. Most states toll the SOL for personal injury claims belonging to minor children until the child turns 18 — meaning surviving NEC children often have claims that will not expire for many years. Parents filing their own claims (wrongful death or loss of consortium) face shorter deadlines. Do not assume your claim is time-barred without consulting a NEC attorney.
NEC Formula Settlements and Verdicts: What Cases Have Resolved and For How Much
NEC formula cases have produced some of the most significant verdicts in the history of mass tort litigation, with individual jury awards ranging from $1.5 million to $495 million. MDL bellwether trials are actively shaping settlement values in 2025-2026. Understanding the landscape of resolved cases helps families calibrate the potential value of their own claims.
Similac NEC Lawsuit: Abbott Laboratories and Similac Special Care Formula
Abbott Laboratories manufactures Similac Special Care — the most widely used cow's milk-based premature infant formula in the United States. Abbott has faced thousands of NEC lawsuits across state and federal courts, with bellwether verdicts in MDL 3026 producing nine-figure jury awards. Families whose premature infants developed NEC after receiving Similac in the NICU may have viable product liability claims against Abbott.
Enfamil NEC Lawsuit: Mead Johnson/Reckitt and Enfamil Premature Formula
Mead Johnson Nutrition — now owned by the British consumer goods giant Reckitt — manufactures Enfamil Premature, a cow's milk-based premature infant formula widely used in NICUs. Mead Johnson has faced some of the largest NEC jury verdicts in history, including a $495 million verdict in Missouri and a $60 million verdict in Illinois. Families whose premature infants received Enfamil in the NICU should contact a NEC attorney immediately.
Why Premature Infants Are Uniquely Vulnerable to NEC
The extreme vulnerability of premature infants to NEC is not an unfortunate coincidence — it is a biological certainty rooted in the profound immaturity of the preterm gut. Understanding why preterm infants are uniquely at risk helps families understand both the medical reality of what happened to their baby and why the NEC risk associated with cow's milk formula should have been disclosed more clearly.
Breast Milk vs. Formula and NEC: AAP Guidelines and the Donor Milk Alternative
The American Academy of Pediatrics, the World Health Organization, and the Human Milk Banking Association of North America all recommend pasteurized donor breast milk — not cow's milk-based formula — as the preferred alternative when a mother's own milk is unavailable for premature infants. The failure of Abbott and Mead Johnson to acknowledge this guidance in their marketing to NICUs is central to the NEC litigation.
NEC MDL 3026 in the Northern District of Illinois: What Families Need to Know
MDL No. 3026 — In Re: Abbott Laboratories, et al., Preterm Infant Formula Products Liability Litigation — is pending before Chief Judge Rebecca R. Pallmeyer in the United States District Court for the Northern District of Illinois. Understanding how the MDL works, what the bellwether trial program has produced, and how your individual case fits into the larger litigation is essential for families considering filing a NEC formula claim.
NEC Wrongful Death Claims: When a Premature Baby Does Not Survive
Losing a premature baby to NEC is an unimaginable tragedy. Families who lost their infants after NEC developed following formula feeding in the NICU may have wrongful death claims against Abbott and Mead Johnson. These cases carry some of the highest verdicts in the NEC litigation — including nine-figure jury awards — because juries respond powerfully to the preventable death of a premature baby.
NEC Long-Term Disabilities: Short Bowel Syndrome, TPN, and Neurodevelopmental Harm
Surviving NEC is only the beginning of a long medical journey for many premature infants. Short Bowel Syndrome, TPN dependency, intestinal failure-associated liver disease, and neurodevelopmental disabilities including cerebral palsy and cognitive impairment are common long-term sequelae of NEC. These lifelong medical needs dramatically increase the damages available in surviving-infant NEC claims.
NEC Hospital Liability: Can the NICU or Hospital Also Be Held Responsible?
In addition to product liability claims against Abbott and Mead Johnson, some NEC families may have medical malpractice claims against the hospital or NICU if the medical team deviated from the standard of care by failing to follow evidence-based breast milk guidelines, failing to inform parents of the NEC risk of formula, or failing to timely diagnose and treat NEC once it developed.
NEC Baby Formula (Similac/Enfamil) Lawsuit
Necrotizing Enterocolitis is one of the most catastrophic diseases affecting premature infants in the United States, striking approximately 12% of very-low-birthweight babies and carrying a mortality rate of 20-30%. Medical research spanning more than two decades has consistently linked cow's milk-based premature infant formula — particularly Similac Special Care (Abbott Laboratories) and Enfamil Premature (Mead Johnson/Reckitt) — to dramatically elevated NEC risk in preterm infants. Studies show that premature infants fed cow's milk-based formula are three to ten times more likely to develop NEC than those fed human breast milk or pasteurized donor breast milk. Despite this well-established scientific evidence and the recommendations of the American Academy of Pediatrics, Abbott and Mead Johnson continued to aggressively market their formula products to NICUs for use in the most vulnerable patient population in medicine. Thousands of families across the country have filed suit against these manufacturers, and the cases are now consolidated in Multi-District Litigation (MDL 3026) in the United States District Court for the Northern District of Illinois, before the Honorable Rebecca R. Pallmeyer. Families who lost a baby to NEC or whose infant survived with lasting harm deserve answers, accountability, and financial compensation for their loss.
View full case overview